Date: August 13, 2026
Regulatory Filing Summary
Sun Pharma Advanced Research Company Ltd (SPARC) has submitted an application with the National Stock Exchange of India Ltd and BSE Limited on August 13, 2026, seeking their no objection/approval for reclassification of certain shareholders from the 'Promoter Group' category to the 'Public' category.
Reclassification Application Details
- The application was made in accordance with Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- This intimation follows earlier communications dated July 27, 2026 and August 10, 2026 regarding the same matter
- The filing is made in compliance with both Regulation 30 and Regulation 31A of the SEBI Listing Regulations
- The application was submitted to both stock exchanges: National Stock Exchange of India Ltd (Exchange Plaza, 5th Floor, Plot No. C/1, G Block, Bandra Kurla Complex, Bandra East, Mumbai - 400 051) and BSE Limited (Market Operations Dept., P.J. Towers, Dalal Street, Mumbai - 400 001)
Compliance Officer Details
- Kajal Damania, Company Secretary and Compliance Officer, digitally signed the document
- Document signed on August 13, 2026 at 16:41:16 IST
Sections Not Specified
Financial Results, Dividend Declaration, Board Meeting Outcomes, Auditor's Report, Disinvestment/Strategic Actions, Media Release/Investor Communication, and Other Operational/Legal/Strategic Disclosures were not covered in this filing.